Clinical Summary: Theronomic Tribiotic Gut Shield is a TGA-registered (ARTG No. 407473) digestive health supplement combining a Gold Kiwifruit prebiotic (Livaux® 277.5 mg), 15 clinically-selected probiotic strains delivering 10 billion CFU per capsule, and a heat-treated postbiotic blend of five Lactobacillus and Bifidobacterium strains totalling 20 billion cells. The tribiotic framework simultaneously seeds, feeds, and protects the gut microbiome. This value bundle provides eight bottles of 30 capsules (240-day supply) with a free SGD 9 voucher, suitable for long-term microbiome maintenance in Singapore adults.
Theronomic Tribiotic Gut Shield — Product Overview
Theronomic Tribiotic Gut Shield represents Australia's first commercially available tribiotic formulation — a category that simultaneously delivers prebiotics, probiotics, and postbiotics in a single capsule dose. Conventional probiotic supplements provide live organisms; postbiotics provide heat-killed bacterial cells and their metabolic by-products; prebiotics provide the fermentable substrates necessary to sustain microbial colonisation. The convergence of all three within a clinically calibrated dose matrix differentiates Gut Shield from single-modality gut supplements.
The Livaux® Gold Kiwifruit prebiotic (Actinidia chinensis) at 277.5 mg is a FODMAP-friendly, clinically validated substrate shown to increase Faecalibacterium prausnitzii abundance — a keystone butyrate-producing species associated with gut barrier integrity and anti-inflammatory activity. The probiotic component features 15 scientifically selected strains targeting bloating, regularity, immunity, and nutrient absorption, while the postbiotic blend of heat-treated strains provides immunomodulatory signals without requiring live organism viability. This eight-bottle bundle is designed for patients undertaking extended gut microbiome rebalancing programs lasting six or more months.
Product Specifications
| Specification |
Detail |
| Manufacturer |
Theronomic Pty Ltd, Australia |
| Regulatory Registration |
TGA ARTG No. 407473 (Therapeutic Goods Administration, Australia); registered 11 April 2023 |
| Prebiotic |
Livaux® Gold Kiwifruit Powder (Actinidia chinensis fruit powder) — 277.5 mg per capsule |
| Probiotic |
15 scientifically-selected multi-strain blend — 10 billion CFU per capsule |
| Postbiotic Strains |
Heat-treated Bifidobacterium animalis subsp. lactis BLC1 (16B cells), L. acidophilus LA1 (1B), L. rhamnosus CRL1505 (1B), L. casei BGP93 (1B), L. plantarum 14D (1B) — 20 billion cells total |
| Total Bioactive Count |
10 billion CFU (live probiotic) + 20 billion cells (postbiotic) per capsule |
| Dosage Form |
Hard capsules; 1–2 capsules daily with food; no refrigeration required |
| Storage |
Store below 25°C in a cool, dry place away from direct sunlight |
| Suitability |
Adults 18+; FODMAP-friendly; suitable for IBS sufferers |
| Bundle Contents |
8 bottles × 30 capsules (240-day supply at 1 capsule/day) + SGD 9 voucher |
Clinical Indications and Key Applications
-
Irritable bowel syndrome (IBS) and bloating: The FODMAP-friendly Livaux® prebiotic is specifically selected for tolerability in IBS populations; multi-strain probiotics address both IBS-D and IBS-C subtypes; clinical improvements in bloating and regularity typically observed within 1–2 weeks
-
Post-antibiotic microbiome restoration: Multi-strain probiotic matrix supports re-establishment of commensal microbial populations following broad-spectrum antibiotic courses; recommended to commence within 2 hours of antibiotic dosing and continue for at least 4 weeks post-treatment
-
Immune system support: L. rhamnosus CRL1505 and heat-killed postbiotic components interact with gut-associated lymphoid tissue (GALT) to modulate mucosal and systemic immune responses; energy and mood benefits typically reported by weeks 3–4
-
Gut barrier integrity and leaky gut management: Faecalibacterium prausnitzii stimulation via Livaux® prebiotic increases butyrate production, supporting tight junction protein expression and reducing intestinal permeability
-
Long-term microbiome maintenance: The 240-day bundle format supports sustained probiotic exposure necessary for durable microbiome remodelling, particularly in patients with chronic digestive conditions
-
Travel and dietary disruption: Shelf-stable formulation (no refrigeration) suitable for use during travel; supports gut homeostasis during dietary changes or periods of irregular eating patterns
Frequently Asked Questions
Q: What does "Tribiotic" mean and how does it differ from a standard probiotic?
A: A tribiotic combines three complementary gut health modalities: a prebiotic (fermentable substrate that feeds beneficial bacteria), a probiotic (live microorganisms), and a postbiotic (heat-killed bacteria that deliver immunomodulatory benefits). Standard probiotics contain only live organisms. Gut Shield's tribiotic framework simultaneously seeds the microbiome (probiotic), feeds it (Livaux® prebiotic), and stimulates immune signalling (heat-treated postbiotic) — addressing the gut microbiome from multiple mechanistic angles in a single capsule.
Q: Is Gut Shield suitable for patients with IBS who are following a low-FODMAP diet?
A: Yes. The Livaux® Gold Kiwifruit prebiotic used in Gut Shield has been specifically validated in FODMAP-sensitive populations. At the 277.5 mg dose, it is well tolerated without triggering fermentative symptoms associated with high-FODMAP prebiotics such as inulin or FOS. Clinical studies confirm it does not exacerbate IBS symptoms while maintaining prebiotic efficacy.
Q: How should Gut Shield be taken alongside antibiotic therapy?
A: Take Gut Shield at least 2 hours before or after antibiotic doses to minimise competitive inhibition of live probiotic strains. Continue for a minimum of 4 weeks following completion of the antibiotic course to support full microbiome restoration. The postbiotic component remains active regardless of antibiotic exposure, providing continuity of gut immune signalling during treatment.
Q: Is Theronomic Tribiotic Gut Shield approved for sale in Singapore?
A: Gut Shield is registered with the Australian Therapeutic Goods Administration (TGA ARTG No. 407473), a recognised international regulatory standard. In Singapore, health supplements are regulated by the Health Sciences Authority (HSA) under its Complementary Health Products framework. EMIS Asia supplies Gut Shield in compliance with applicable HSA import and distribution guidelines. Healthcare professionals and patients in Singapore should consult a clinician before commencing supplementation for therapeutic purposes.
Q: What makes the eight-bottle bundle the preferred format for gut health protocols?
A: Durable microbiome remodelling requires sustained exposure over months, not weeks. Research on probiotic interventions consistently shows that strain colonisation, immune modulation, and symptom resolution peak at 3–6 months of continuous supplementation. The eight-bottle format (240-day supply) provides a clinically appropriate treatment duration at a reduced cost per serving compared to single-bottle purchasing, making it the recommended format for patients committed to long-term gut health optimisation.
